Statements (38)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
benzodiazepine |
| gptkbp:approvedBy |
gptkb:Argentina
gptkb:Mexico gptkb:South_Africa gptkb:Spain |
| gptkbp:ATCCode |
N05BA10
|
| gptkbp:brand |
Talis
Anseren Ketam Marcen Sedatival |
| gptkbp:CASNumber |
509-65-9
|
| gptkbp:eliminationHalfLife |
26-200 hours
|
| gptkbp:hasMolecularFormula |
C16H13ClN2O
|
| gptkbp:hasSMILES |
Clc1ccc2c(c1)C(=O)Nc3ccccc3N2C
|
| gptkbp:hasUNII |
0W8RRI6W5A
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ketazolam
|
| gptkbp:isMetabolizedTo |
gptkb:diazepam
|
| gptkbp:isNotApprovedIn |
gptkb:United_Kingdom
gptkb:United_States |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:pregnancyCategory |
gptkb:D_(Australia)
D (United States) |
| gptkbp:prodrugOf |
gptkb:diazepam
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2104707
3691 3822 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fatigue
muscle weakness drowsiness ataxia |
| gptkbp:usedFor |
treatment of anxiety
treatment of muscle spasms |
| gptkbp:wasFirstDescribed |
1960s
|
| gptkbp:bfsParent |
gptkb:N05BA
|
| gptkbp:bfsLayer |
7
|